Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Quantum-Si Incorporated (QSI) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Medical Devices
$1.73
-0.08 (-4.42%)Did QSI Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Quantum-Si is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, QSI has a bullish consensus with a median price target of $3.50 (ranging from $1.00 to $4.00). Currently trading at $1.73, the median forecast implies a 102.3% upside. This outlook is supported by 2 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Swayampakula Ramakanth at HC Wainwright & Co., projecting a 131.2% upside. Conversely, the most conservative target is provided by Kyle Mikson at Canaccord Genuity, suggesting a 42.2% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for QSI.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 19, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $0.00 |
Feb 7, 2025 | Alliance Global Partners | Scott Henry | Buy | Initiates | $3.75 |
Jan 14, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $5.50 |
Nov 21, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $5.50 |
Nov 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $4.00 |
Nov 13, 2024 | Canaccord Genuity | Kyle Mikson | Hold | Maintains | $1.00 |
May 10, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $4.00 |
Mar 1, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $4.00 |
Dec 8, 2023 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Initiates | $3.00 |
Sep 25, 2023 | Canaccord Genuity | Kyle Mikson | Hold | Downgrade | $2.00 |
Oct 20, 2021 | Canaccord Genuity | Kyle Mikson | Buy | Initiates | $13.00 |
The following stocks are similar to Quantum-Si based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Quantum-Si Incorporated has a market capitalization of $348.94M with a P/E ratio of -2.4x. The company generates $3.44M in trailing twelve-month revenue with a 52.3% profit margin.
Revenue growth is +84.2% quarter-over-quarter, while maintaining an operating margin of -2,982.4% and return on equity of -40.2%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Revolutionizing proteomics with semiconductor technology.
The company develops and commercializes a semiconductor chip-based platform for analyzing and sequencing proteins, generating revenue through the sale of this innovative technology to sectors like pharmaceuticals, biotechnology, and clinical diagnostics.
Quantum-Si Incorporated's platform aims to provide faster, more comprehensive proteome insights at a lower cost, which enhances accessibility and applicability in drug discovery, biomarker identification, and personalized medicine. Its position in the emerging technology space signifies potential for transformative impact in healthcare and research, attracting interest from both tech and healthcare investors.
Healthcare
Medical Devices
149
Mr. Jeffrey Alan Hawkins
United States
2021
U.S. stock futures are mixed, with Dow futures up approximately 0.1% on Monday.
Mixed U.S. stock futures indicate market uncertainty and varying investor sentiment, which can affect trading strategies and portfolio adjustments.
Quantum-Si Incorporated has announced a $50 million registered direct offering of common stock.
The $50 million stock offering indicates Quantum-Si's capital-raising efforts, potentially impacting share dilution and funding for growth initiatives, influencing investor sentiment and stock performance.
Quantum-Si has placed its Platinumยฎ Pro Instrument at the Broad Institute to enhance regional research initiatives.
The placement of Quantum-Si's technology at a prestigious research institute signals potential growth in demand for its products, possibly enhancing future revenue and market position.
Quantum-Si's customer will present protein barcoding for nucleic acid-LNP therapeutic development at the Festival of Genomics in Boston.
The showcase highlights Quantum-Si's advancements in protein barcoding technology, signaling potential growth and innovation in the biotech sector, influencing investor sentiment and stock performance.
Quantum-Si will participate in a GenomeWeb webinar on proteomics data integration and standardization alongside experts from DNAnexus, Olink, and Northwestern.
Quantum-Si's collaboration with industry leaders in a webinar highlights its commitment to advancing proteomics, potentially enhancing its market position and attracting investor interest.
Quantum-Si has announced inducement grants in compliance with Nasdaq Listing Rule 5635(c)(4).
Quantum-Si's inducement grants may impact its stock valuation and investor sentiment, indicating potential growth or strategic shifts following its Nasdaq listing.
Based on our analysis of 3 Wall Street analysts, Quantum-Si Incorporated (QSI) has a median price target of $3.50. The highest price target is $4.00 and the lowest is $1.00.
According to current analyst ratings, QSI has 2 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.73. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict QSI stock could reach $3.50 in the next 12 months. This represents a 102.3% increase from the current price of $1.73. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company develops and commercializes a semiconductor chip-based platform for analyzing and sequencing proteins, generating revenue through the sale of this innovative technology to sectors like pharmaceuticals, biotechnology, and clinical diagnostics.
The highest price target for QSI is $4.00 from Swayampakula Ramakanth at HC Wainwright & Co., which represents a 131.2% increase from the current price of $1.73.
The lowest price target for QSI is $1.00 from Kyle Mikson at Canaccord Genuity, which represents a -42.2% decrease from the current price of $1.73.
The overall analyst consensus for QSI is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $3.50.
Stock price projections, including those for Quantum-Si Incorporated, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.